Gm2052基因在小鼠胚胎发育中表达的初步研究

目的:研究预测的编码蛋白基因Gm2052在小鼠胚胎发育阶段的表达模式,为进一步了解该基因的功能奠定基础。方法:通过全胚胎原位杂交技术、组织切片原位杂交技术及半定量RT-PCR方法,对预测的Gm2052基因在小鼠胚胎发育中后期及在新生小鼠中的表达情况进行初步分析。结果:全胚胎原位杂交显示,在E10.5小鼠胚胎中,Gm2052仅在脑中表达;当小鼠胚胎发育至E13.5时,Gm2052在脑、舌、肺、肝脏、胰腺等组织中均有表达。半定量RT-PCR结果显示,在小鼠胚胎中后期(E15.5和E18.5)及新生小鼠(出生后第9 d)中,Gm2052呈动态表达模式。结论:预测基因Gm2052与小鼠脑的发育密切相关,并可能参与小鼠肺、肝脏及胰腺等主要脏器胚期的发育。     

印记基因Dlk1在小鼠胚胎发育中的表达分析

目的:研究印记基因Dlk1在小鼠胚胎发育过程中的动态表达模式,以揭示Dlk1与胚胎发育的关系。方法:通过半定量PCR和定量PCR分析Dlk1在小鼠胚胎发育E8.5～E19.5的基因表达模式,并选取Dlk1表达量最高的时期进行胚胎切片原位杂交和组织定量PCR分析。结果:在小鼠胚胎发育E8.5～E15.5时,Dlk1的表达逐渐升高,在E15.5时表达量达到最高;E15.5～E19.5时,Dlk1表达有所下降,但仍然维持较高水平。E15.5切片原位杂交显示,垂体、肺脏、软骨、舌和背侧肌肉组织中Dlk1表达较高,组织定量PCR实验进一步证实了原文杂交的结果。结论:Dlk1在小鼠胚胎发育中后期持续表达,并呈现一定的组织特异性,对胚胎发育可能起重要的调节作用。     

Ypel3基因在小鼠胚胎发育中的表达与调控

目的:探讨小鼠胚胎发育过程中Ypel3基因的时空特异性表达与调控,为后续功能研究奠定基础。方法:选取胎龄(E)10.5、12.5、14.5、16.5和18.5 d的小鼠胚胎,利用荧光定量RT-PCR技术研究Ypel3基因mRNA的时序性动态表达谱;采用原位杂交技术观察Ypel3基因mRNA在胚胎发育E11.5和E15.5的空间表达谱;应用定量RT-PCR技术检测表观遗传学修饰对Ypel3基因mRNA表达丰度的影响。结果:定量RT-PCR表明该基因从胚胎发育的早中期开始表达,到出生前表达量呈逐渐升高趋势;原位杂交显示E11.5信号出现在脑和心脏中,E15.5信号在脑、舌、心、肺、胸腺、肝、肾等主要脏器中均有表达;甲基化转移酶抑制剂5-氮胞苷(5-Aza)处理的Neuro-2a(N2a)细胞中,Ypel3的表达水平未产生显著变化,而去乙酰化酶抑制剂4-苯丁酸(4-PBA)处理后该基因表达显著升高,5-Aza和4-PBA联合处理后表达水平进一步升高。结论:Ypel3基因在小鼠胚胎发育各阶段有广泛的表达,提示其具有重要作用,且该基因的表达可能受到组蛋白乙酰化的调控。     

对与小鼠胚胎发育相关的印记基因Mcts2的研究

目的：对与小鼠胚胎发育相关的印记基因Mcts2表达模式及生物学功能做初步的分析。方法：采用切片原位杂交,全胚胎原位杂交,Northern blot和real-time PCR对该基因进行了表达谱的分析。结果：切片原位杂交结果显示Mcts2基因在E13.5和E15.5胚胎中的脑、舌、心脏、肺脏、肝脏、肾脏等重要脏器中都有普遍表达。全胚胎原位杂交结果显示Mcts2基因在E10.5胚胎中的前脑、前肢、尾芽中出现较强的信号,其他部位信号较弱。Northern和Real-time PCR实验分析了Mcts2基因在E12.5,E15.5,E18.5胚胎和新生小鼠的脑、心脏、肺脏、肝脏和肾脏中的表达谱,发现Mcts2基因在这几个主要发育时期都有普遍表达,在E15.5胚胎中表达信号最为强烈。结论：Mcts2基因在小鼠胚胎的发育的各主要时期的重要脏器中都有普遍的表达,提示该基因在小鼠胚胎发育过程中起到了重要的作用。     

AI429618基因在小鼠胚期表达的研究

目的:通过对与小鼠胚胎发育相关的新基因AI429618表达模式的初步分析为揭示小鼠胚胎发育机理提供研究基础.方法:利用Northern-blot和原位杂交方法对该基因进行表达谱分析.结果:Northern结果表明该基因在E12.5,E.15.5,E18.5三个时期都有所表达,并且在E12.5的小鼠胚胎中处于一个相对较高的转录水平,E15.5表达骤降并且基本上与E18.5(略高)持平;原位杂交结果显示E9.5,E10.5的小鼠胚胎中这一基因的表达集中在端脑、中脑、后脑、腮弓、前肢芽以及尾芽,E15.5的切片原位杂交中这一基因的表达信号在胸腺,肺,肝,肾,小肠中极为显著.结论:AI429618基因在小鼠胚胎发育期有着持续广泛的表达,可能对胚胎的正常发育起着重要的调控作用.     

与小鼠胚胎发育相关新基因0610038D11Rik的研究

目的:初步分析与小鼠胚胎发育相关的新基因0610038D11Rik表达模式及生物学功能.方法:采用RT-PCR,全胚胎原位杂交和Northern Blotting技术对该基因进行表达谱分析;细胞免疫染色对其进行细胞结构定位.结果:全胚胎原位杂交结果显示0610038D11Rik在胚胎E9.5的端脑、间脑、菱脑和听泡处有较强的信号.随着神经管逐渐关闭,胚胎E10.5在背部神经嵴,神经管区也出现表达信号.E11.5时除了在上述部位表达外,心脏部位也检测到较弱的信号.RT-PCR和Northern Blot实验发现该基因在小鼠胚胎发育直至出生后均有持续性分布,并且在发育中后期的脑、心脏、肺、肾、肝脏,肌肉和舌等多种重要脏器广泛表达.细胞定位表明其主要集中在核内和细胞质中.结论:0610038D11Rik基因在小鼠的脑神经系统和多器官表达,提示该新基因可能在这些组织的发育过程中发挥重要的作用.     

Rb基因在小鼠胚胎发育中期肾组织的表达

用原位杂交法检测小鼠肾组织中细胞周期调控基因Rb的表达;用免疫组织化学及缺口末端标记法观察小鼠肾组织发育过程中的细胞增殖与凋亡：结果表明,Rb基因主要在肾上皮细胞表达,随胎龄增长而表达颜色加深。肾组织在第13天有一个较大的增殖增长,到第14天生长趋于稳定。以上结果说明Rb基因在小鼠胚胎肾发育中期有表达,该基因在胚胎肾发育中期起一定的作用;同时胚胎发育中期肾细胞增殖与凋亡相伴存在。     

3110009F21Rik基因在小鼠胚胎发育中的表达研究

目的:探讨小鼠胚胎发育过程中3110009F21Rik基因的时空特异性表达模式,为后续功能研究奠定基础。方法:对E15.5小鼠胚胎脑组织进行印记分析,检测基因的印记表达状态;应用全胚胎和组织原位杂交技术检测3110009F21Rik基因在E9.5~E15.5小鼠胚胎中的特异性时空表达模式。结果:印记分析显示3110009F21Rik基因在E15.5脑组织中为父母本等位基因双表达;原位杂交结果显示3110009F21Rik基因在E9.5~E15.5脑组织中持续表达,在E9.5~E11.5主要脏器中未检测到,但自E12.5开始在主要脏器中持续表达,随着发育进程进行,目的基因在胚胎骨骼中的相对表达水平逐步升高,至E15.5阶段大部分骨骼中都检测到目的基因表达。结论:3110009F21Rik基因在脑组织中的持续表达和表达模式的动态变化提示其可能参与胚胎发育过程中大脑神经网络的构建,其在软骨原基和软骨中的相对表达逐渐增强表明其可能参与了小鼠胚胎过程中骨的发育和形成及软骨分化。     

难免流产蜕膜组织遗传印记基因PEG10的表达

采用半定量逆转录聚合酶反应(RT-PCR)、原位杂交、免疫印记(Western blot)及免疫组织化学技术检测了36例难免流产患者蜕膜组织PEG10 (Paternally expressed gene 10) mRNA及蛋白的表达与分布, 并以36例同期正常早孕妇女为对照, 研究遗传印记基因在难免流产蜕膜组织中的表达, 探讨其在自然流产中的作用。RT-PCR结果显示, PEG10在两组蜕膜组织中均有表达, 正常妊娠组平均表达水平为0.5994±0.049, 难免流产组为0.1783±0.037, 两组比较具有显著性差异(P<0.05)。原位杂交、免疫组化及Western blot分析也显示PEG10的表达规律与RT-PCR结果相吻合。研究结果表明, 遗传印记基因PEG10维持一定水平的表达对早期胚胎发育和正常妊娠的维持有重要意义, 而其表达下调可能是导致难免流产的原因之一。     

Developmental expression of plasma glutathione peroxidase during mouse organogenesis

Plasma glutathione peroxidase (pGPx) is an extracellular antioxidative selenoenzyme which has been detected in various adult tissues, but little is known about the expression and distribution of pGPx during embryogenesis. To investigate the expression patterns of pGPx during embryogenesis, we performed quantitative real-time PCR, in situ hybridization, Western blot, and immunohistochemistry analyses in whole embryos or each developing organ of mice on embryonic days (E)7.5–18.5. In whole embryos of E7.5–8.5, pGPx mRNA was more typically expressed in extra-embryonic tissues including ectoplacental cone, trophectoderm, and decidual cells than in embryos. However, after E9.5, pGPx mRNA and protein levels were increased in the embryos with differentiation and growth, but trended to gradually decrease in the extra-embryonic tissues until E18.5. In sectioned embryonic tissues on E13.5–18.5, pGPx mRNA and protein were mainly expressed in the developing nervous tissues, the sensory organs, and the epithelia of lung, skin, and intestine, the heart and artery, and the kidney. In particular, pGPx immunoreactivity was very strong in the developing liver. These results indicate that pGPx is spatio-temporally expressed in various embryonic organs as well as extra-embryonic tissues, suggesting that pGPx may function to protect the embryos against endogenous and exogenous reactive oxygen species during organogenesis.     

Spatiotemporal expression of the selenoprotein P gene in postimplantational mouse embryos

Selenoprotein P (Sepp) is an extracellular glycoprotein which functions principally as a selenium (Se) transporter and antioxidant. In order to assess the spatiotemporal expression of the Sepp gene during mouse embryogenesis, quantitative RT-PCR and in situ hybridization analyses were conducted in embryos and extraembryonic tissues, including placenta. Sepp mRNA expression was detected in all embryos and extraembryonic tissues on embryonic days (E) 7.5 to 18.5. Sepp mRNA levels were high in extraembryonic tissues, as compared to embryos, on E 7.5-13.5. However, the levels were higher in embryos than in extraembryonic tissues on E 14.5-15.5, but were similar in both tissues during the subsequent periods prior to birth. According to the results of in situ hybridization, Sepp mRNA was expressed principally in the ectoplacental cone and neural ectoderm, including the neural tubes and neural folds. In whole embryos, Sepp mRNA was expressed abundantly in nervous tissues on E 9.5-12.5. Sepp mRNA was also expressed in forelimb and hindlimb buds on E 10.5-12.5. In the sectioned embryos, on E 13.5-18.5, Sepp mRNA was expressed persistently in the developing limbs, gastrointestinal tract, nervous tissue, lung, kidney and liver. On E 16.5-18.5, Sepp mRNA expression in the submandibular gland, whisker follicles, pancreas, urinary bladder and skin was apparent. In particular, Sepp mRNA was detected abundantly in blood cells during all the observed developmental periods. These results show that Sepp may function as a transporter of selenium, as well as an antioxidant, during embryogenesis.     

Conserved expression of the PRELI domain containing 2 gene (<Emphasis Type="Italic">Prelid2</Emphasis>) during mid-later-gestation mouse embryogenesis

Prelid2, which belongs to the PRELI domain containing family, is identified as a conserved evolution gene. The expression and regulation during embryonic development of the prelid2 gene is unknown. In this study, we investigated the prelid2 gene expression and regulation using mouse embryos model, by in situ hybridization analysis, RT-PCR and bisulfite sequencing. In situ hybridization analysis showed that prelid2 gene expression were found in midbrain, spinal cord, optic eminence, otic vesicle and tail at E9.5 and E10.5 embryos, in forebrain, hindbrain, heart, lung, liver and kidney at E13.5 and E15.5 embryos. Real-time quantitative RT-PCR results verified the expression pattern in the four major mouse organs, brain, heart, lung, and liver during organs differentiation and formation. Bisulfite sequencing illustrated the consistent result of expression and its unmethylation status in the genomic promoter region at E12.5, E18.5, and new born. Thus, the prelid2 gene is a widely-spread, persistently expressed and unmethylated gene in mouse embryonic development. Our results suggest that the PRELI domain containing 2 gene is involved in mouse embryonic development.     

Expression profiles of extracellular superoxide dismutase during mouse organogenesis

Although extracellular superoxide dismutase (EC-SOD), which scavenges the superoxide anion in extracellular spaces, has previously been implicated in the prenatal pulmonary response to oxidative stress in the developing lungs, little is currently known regarding the schematic expression pattern and the roles played by EC-SOD during embryogenesis. In an effort to characterize the pattern of EC-SOD expression during mouse organogenesis, quantitative RT-PCR, Western blotting, and in situ hybridization analyses were conducted in mouse embryos and extraembryonic tissues including placenta on embryonic days (Eds) 7.5-18.5. EC-SOD mRNA and protein were expressed in all the embryos and extraembryonic tissues examined. The mRNA level was higher in the embryos than the extraembryonic tissues on Eds 7.5-10.5, but after Ed 13.5, it evidenced an increasing pattern in the extraembryonic tissues. EC-SOD immunoreactivity also increased in the extraembryonic tissues after Ed 13.5. During organogenesis, EC-SOD mRNA was expressed principally in the ectoplacental cone, amnion, and neural ectoderm on Ed 7.5 and in the neural folds and primitive streak on Ed 8.5. On Eds 9.5-12.5, EC-SOD mRNA was expressed abundantly in the nervous tissues and forelimb and hindlimb buds. On Eds 13.5-18.5, EC-SOD mRNA was observed at high levels in the airway epithelium of lung, liver, the intestinal epithelium, skin, vibrissae, the metanephric corpuscle of kidney, the nasal cavity, and the labyrinth trophoblast, spongiotrophoblast, and blood cells in placenta. Our overall results indicate that EC-SOD is expressed spatiotemporally in developing embryos and surrounding extraembryonic tissues during mouse organogenesis, thus suggesting that EC-SOD may be relevant to organogenesis, playing the role of an antioxidant enzyme against endogenous and exogenous oxygen stresses.